Cardiff Oncology, Inc. (CRDF)

2.965 +0.08 (+2.60%) USD  |  NASDAQ  |  Jan 22, 16:00
2.965 0.00 (0.00%) After-Hours: 16:11
More

Cardiff Oncology Stock Based Compensation (Per Share Quarterly)

Stock Based Compensation (Per Share Quarterly) Chart

View Stock Based Compensation (Per Share Quarterly) for CRDF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Per Share Quarterly) Range, Past 5 Years

View Stock Based Compensation (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Per Share Quarterly) Benchmarks

View Stock Based Compensation (Per Share Quarterly) Benchmarks
Start Trial
Agenus, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade